tiprankstipranks
JBM (Healthcare) Ltd. (HK:2161)
:2161
Hong Kong Market

JBM (Healthcare) Ltd. (2161) Ratios

4 Followers

JBM (Healthcare) Ltd. Ratios

HK:2161's free cash flow for Q2 2025 was HK$0.59. For the 2025 fiscal year, HK:2161's free cash flow was decreased by HK$ and operating cash flow was HK$0.35. See a summary of the company’s cash flow.
Ratios
TTM
Mar 24Mar 23Mar 22Mar 22
Liquidity Ratios
Current Ratio
2.91 1.61 1.66 2.06 1.70
Quick Ratio
2.41 1.32 1.25 1.69 1.42
Cash Ratio
1.04 0.73 0.64 0.54 0.78
Solvency Ratio
0.42 0.65 0.48 0.20 0.27
Operating Cash Flow Ratio
1.00 0.81 0.86 0.47 0.75
Short-Term Operating Cash Flow Coverage
9.28 1.51 2.69 1.00 1.60
Net Current Asset Value
HK$ -98.11MHK$ 71.19MHK$ 791.00KHK$ -98.56MHK$ -41.01M
Leverage Ratios
Debt-to-Assets Ratio
0.22 0.11 0.10 0.16 0.13
Debt-to-Equity Ratio
0.36 0.16 0.14 0.23 0.18
Debt-to-Capital Ratio
0.26 0.14 0.12 0.19 0.15
Long-Term Debt-to-Capital Ratio
0.24 0.00 0.04 0.11 0.06
Financial Leverage Ratio
1.65 1.43 1.43 1.43 1.42
Debt Service Coverage Ratio
11.05 1.68 2.42 1.16 0.98
Interest Coverage Ratio
46.35 55.12 20.50 5.68 8.26
Debt to Market Cap
0.17 0.10 0.14 0.22 0.16
Interest Debt Per Share
0.48 0.22 0.16 0.25 0.21
Net Debt to EBITDA
0.58 -0.11 -0.03 1.70 0.25
Profitability Margins
Gross Profit Margin
56.76%52.88%52.14%35.04%36.12%
EBIT Margin
33.83%31.46%26.74%9.15%16.36%
EBITDA Margin
40.41%38.15%34.04%20.72%21.41%
Operating Profit Margin
31.74%31.45%26.87%8.95%13.02%
Pretax Profit Margin
33.24%30.89%25.43%8.01%15.15%
Net Profit Margin
26.62%25.22%20.12%6.06%10.97%
Continuous Operations Profit Margin
27.56%25.91%21.16%5.74%12.17%
Net Income Per EBT
80.08%81.63%79.12%75.67%72.42%
EBT Per EBIT
104.73%98.21%94.65%89.48%116.32%
Return on Assets (ROA)
12.21%12.77%9.39%1.85%4.07%
Return on Equity (ROE)
20.10%18.23%13.44%2.65%5.79%
Return on Capital Employed (ROCE)
16.27%19.47%14.93%3.02%5.61%
Return on Invested Capital (ROIC)
13.20%14.46%11.60%2.19%4.28%
Return on Tangible Assets
28.54%27.18%24.24%10.53%21.39%
Earnings Yield
10.02%13.45%16.40%3.03%5.93%
Efficiency Ratios
Receivables Turnover
3.85 5.78 5.96 3.01 4.64
Payables Turnover
14.22 17.28 14.00 11.83 11.08
Inventory Turnover
3.81 4.48 3.39 5.51 6.09
Fixed Asset Turnover
4.80 4.79 4.24 2.24 3.15
Asset Turnover
0.46 0.51 0.47 0.30 0.37
Working Capital Turnover Ratio
3.09 4.93 4.59 2.87 3.82
Cash Conversion Cycle
164.89 123.42 142.86 156.77 105.70
Days of Sales Outstanding
94.84 63.11 61.21 121.38 78.71
Days of Inventory Outstanding
95.72 81.44 107.72 66.23 59.91
Days of Payables Outstanding
25.67 21.13 26.08 30.84 32.93
Operating Cycle
190.56 144.55 168.93 187.61 138.63
Cash Flow Ratios
Operating Cash Flow Per Share
0.23 0.28 0.22 0.07 0.16
Free Cash Flow Per Share
0.19 0.25 0.20 0.06 0.15
CapEx Per Share
0.04 0.03 0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.84 0.91 0.95 0.88 0.94
Dividend Paid and CapEx Coverage Ratio
1.10 2.28 3.04 8.50 11.58
Capital Expenditure Coverage Ratio
6.19 10.80 18.72 8.50 17.94
Operating Cash Flow Coverage Ratio
0.48 1.32 1.43 0.28 0.81
Operating Cash Flow to Sales Ratio
0.23 0.29 0.29 0.15 0.28
Free Cash Flow Yield
7.18%14.04%22.75%6.51%14.31%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
9.98 7.43 6.10 33.03 16.86
Price-to-Sales (P/S) Ratio
2.66 1.87 1.23 2.00 1.85
Price-to-Book (P/B) Ratio
2.02 1.36 0.82 0.88 0.98
Price-to-Free Cash Flow (P/FCF) Ratio
13.92 7.12 4.40 15.36 6.99
Price-to-Operating Cash Flow Ratio
11.63 6.46 4.16 13.55 6.60
Price-to-Earnings Growth (PEG) Ratio
1.20 0.12 0.05 3.63 0.13
Price-to-Fair Value
2.02 1.36 0.82 0.88 0.98
Enterprise Value Multiple
7.17 4.80 3.57 11.37 8.89
Enterprise Value
2.35B 1.43B 788.11M 956.51M 990.46M
EV to EBITDA
7.17 4.80 3.57 11.37 8.89
EV to Sales
2.90 1.83 1.22 2.36 1.90
EV to Free Cash Flow
15.13 6.96 4.35 18.06 7.19
EV to Operating Cash Flow
12.69 6.31 4.12 15.94 6.79
Tangible Book Value Per Share
1.39 0.42 0.19 -0.14 -0.12
Shareholders’ Equity Per Share
1.31 1.32 1.10 1.04 1.11
Tax and Other Ratios
Effective Tax Rate
0.17 0.16 0.17 0.23 0.17
Revenue Per Share
1.00 0.95 0.73 0.45 0.58
Net Income Per Share
0.27 0.24 0.15 0.03 0.06
Tax Burden
0.80 0.82 0.79 0.76 0.72
Interest Burden
0.98 0.98 0.95 0.88 0.93
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.25 0.24 0.06 0.11 0.10
Stock-Based Compensation to Revenue
0.00 <0.01 0.01 0.00 <0.01
Income Quality
0.86 0.94 1.47 2.44 2.56
Currency in HKD